(Q80796096)
Statements
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT (English)
Volker Möbus
Hannes Wandt
Norbert Frickhofen
Carmelo Bengala
Kim Champion
Rainer Kimmig
Helmut Ostermann
Axel Hinke
Jonathan A Ledermann
AGO-Ovar/AIO